A Multicenter, Prospective, Observational, Real-World Registry Study of Intravenous Tenecteplase in Very Old Patients With Acute Ischemic Stroke
Status: Recruiting
Location: See location...
Intervention Type: Other, Drug
Study Type: Observational
SUMMARY
The benefit of intravenous tenecteplase in very old patients with acute ischemic stroke (AIS) remain uncertain. This real-world study aims to evaluate the effectiveness and safety of intravenous tenecteplase in AIS patients aged 80 years or older within 4.5 hours of symptom onset.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 80
Healthy Volunteers: f
View:
• Age \> 80 years;
• Clinically diagnosed with acute ischemic stroke and arrived at the hospital within 4.5 hours of symptom onset;
• Informed consent signed by the patient or legally authorized representative.
Locations
Other Locations
China
The First Affiliated Hospital of Guangxi Medical University
RECRUITING
Nanning
Contact Information
Primary
Dong Pan, MD, PhD
dongpan012@hotmail.com
86-156 2648 3251
Time Frame
Start Date: 2026-03-22
Estimated Completion Date: 2027-12
Participants
Target number of participants: 392
Treatments
Control group
Standard medical treatment
Tenecteplase group
Intravenous tenecteplase thrombolysis
Related Therapeutic Areas
Sponsors
Leads: First Affiliated Hospital of Guangxi Medical University